The pitch sounds straightforward enough: what if building HIPAA-compliant healthcare software didn't require an army of engineers and months of regulatory handwringing?
That's the bet Blaze is making. The Los Angeles startup announced an $8.5 million pre-seed round in early August, disclosed via LinkedIn with a pointer to an Axios Pro Health Tech Deals report. For a company operating in the niche intersection of no-code platforms and healthcare compliance, it's a sizable raise—especially in a fundraising climate where digital health investors have grown considerably more discerning.
The details remain sparse. Axios Pro keeps its syndicate reporting behind a paywall, so the lead investor and full participant list aren't public. But the size alone is telling. Pre-seed rounds of this magnitude suggest either unusually strong early traction or investor conviction that the infrastructure play is bigger than it appears.
A Second Bite at Pre-Seed
This isn't Blaze's first turn at the pre-seed well. The company raised $3.5 million at the end of 2022, announced the following January, in a round co-led by Flybridge Capital and MaC Venture Capital. TechCrunch covered it at the time. Since then, Black Opal Ventures and K8 Capital have joined the cap table—additions that co-founder Nanxi Liu highlighted in LinkedIn posts as growth accelerators.
Liu and co-founder Tina Denuit-Wojcik come with some pedigree. They previously built Enplug, a digital signage platform that was acquired in 2021. Now they're tackling a different problem: the friction healthcare organizations face when trying to turn AI-generated prototypes into production software that won't land them in regulatory hot water.
According to LinkedIn, Blaze currently employs somewhere between 11 and 50 people, with 27 profiles visible on the platform. Not massive, but not a garage operation either.
The Compliance Gauntlet
Here's where things get specific. Blaze markets itself around HIPAA compliance, SOC 2 Type II certification, and HITRUST e1 status—the latter achieved in late 2025, according to a company LinkedIn post. Those certifications aren't trivial; they're the bureaucratic gauntlet that keeps many digital health products from ever reaching market.
The platform's feature set reads like a wish list for healthcare IT teams: integrations with Epic, athenahealth, and Cerner. E-prescribing workflows. Claims and eligibility checks. Custom telehealth builds. Audit logging that satisfies compliance officers.
Blaze claims on its website and LinkedIn to be "the only no-code platform with HIPAA compliance and HITRUST e1." Maybe. The healthcare tech space is crowded and full of marketing hyperbole, so any "only" claim deserves a healthy dose of skepticism. Still, the combination of no-code tooling and baked-in regulatory compliance does narrow the field considerably.
Money in a Cautious Market
Digital health funding in the first half of 2026 hit $7.4 billion, according to Rock Health data cited by Becker's Hospital Review in July. That's not nothing, but it's also not the free-for-all of years past. Investors now scrutinize adoption pathways and unit economics with the kind of attention previously reserved for late-stage deals.
Recent comparables offer some context. XCaliber Health raised $6.5 million in May for an agentic operating system. Chromie Health pulled together $2 million for an SMS-based AI staffing agent around the same time. Cadence, further along, secured $100 million in late June to layer AI agents onto its remote patient monitoring platform.
Blaze's $8.5 million sits well above typical pre-seed territory, which raises questions. Has the company already demonstrated significant customer adoption? Or are investors simply betting that healthcare's interoperability mess and perpetual developer shortage create a structural tailwind for compliance-native infrastructure?
The Road Ahead
Blaze says it will deploy the fresh capital toward helping teams convert AI-generated workflows into compliant, deployable software. Use cases already span e-prescribing, EHR integrations, telehealth, and audit functions—areas where healthcare organizations routinely stumble over both technical complexity and regulatory requirements.
The thesis makes sense on paper. Healthcare systems are drowning in interoperability challenges and don't have infinite developer bandwidth. A no-code platform that handles compliance out of the box could theoretically shortcut both problems at once.
Whether that thesis holds in practice is another question entirely. The gap between "works for early adopters" and "scales into core payer and health system workflows" is littered with promising healthcare IT startups that couldn't bridge it. Blaze will need to prove it's different—that compliance-first positioning translates into market share, and that no-code can handle the gnarly edge cases that tend to derail elegant platform promises.
For now, though, the company has runway. And in a market where capital has grown selective, that's worth something.
